Literature DB >> 22258547

Use of hydroxychloroquine in corticodependent and recurrent scleritis.

Célia Maschi, Nathalie Tieulié, Pierre Gastaud, Stéphanie Baillif.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22258547     DOI： 10.1007/s00417-011-1922-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  10 in total

1.  Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis.

Authors:  Adrian W Jachens; David S Chu
Journal:  Am J Ophthalmol       Date:  2008-03       Impact factor: 5.258

2.  Azathioprine for ocular inflammatory diseases.

Authors:  Sirichai Pasadhika; John H Kempen; Craig W Newcomb; Teresa L Liesegang; Siddharth S Pujari; James T Rosenbaum; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; Eric B Suhler
Journal:  Am J Ophthalmol       Date:  2009-07-01       Impact factor: 5.258

3.  Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.

Authors:  Simon R J Taylor; Alan D Salama; Lavnish Joshi; Charles D Pusey; Susan L Lightman
Journal:  Arthritis Rheum       Date:  2009-05

4.  Antineutrophil cytoplasmic antibody-associated active scleritis.

Authors:  Lani T Hoang; Lyndell L Lim; Brian Vaillant; Dongseok Choi; James T Rosenbaum
Journal:  Arch Ophthalmol       Date:  2008-05

5.  Evaluation of patients with scleritis for systemic disease.

Authors:  Esen Karamursel Akpek; Jennifer E Thorne; Faqir A Qazi; Diana V Do; Douglas A Jabs
Journal:  Ophthalmology       Date:  2004-03       Impact factor: 12.079

6.  [Hydroxychloroquine and systemic lupus: a reappraisal].

Authors:  N Costedoat-Chalumeau; G Leroux; Z Amoura; J-C Piette
Journal:  Rev Med Interne       Date:  2007-06-21       Impact factor: 0.728

7.  An analysis of therapeutic decision for scleritis.

Authors:  M Sainz de la Maza; N S Jabbur; C S Foster
Journal:  Ophthalmology       Date:  1993-09       Impact factor: 12.079

8.  Mycophenolate mofetil for ocular inflammation.

Authors:  Ebenezer Daniel; Jennifer E Thorne; Craig W Newcomb; Siddharth S Pujari; R Oktay Kaçmaz; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; C Stephen Foster; Douglas A Jabs; John H Kempen
Journal:  Am J Ophthalmol       Date:  2009-12-30       Impact factor: 5.258

9.  Cyclosporine for ocular inflammatory diseases.

Authors:  R Oktay Kaçmaz; John H Kempen; Craig Newcomb; Ebenezer Daniel; Sapna Gangaputra; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; Grace A Levy-Clarke; C Stephen Foster
Journal:  Ophthalmology       Date:  2010-01-19       Impact factor: 12.079

10.  Infliximab for the treatment of refractory scleritis.

Authors:  Priyanka Doctor; Amyna Sultan; Sana Syed; William Christen; Pooja Bhat; C Stephen Foster
Journal:  Br J Ophthalmol       Date:  2009-12-02       Impact factor: 4.638
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.